
Sanders Capital’s Gilead Sciences GILD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-11,392,884
| Closed | -$740M | – | 41 |
|
2019
Q4 | $740M | Buy |
11,392,884
+194,791
| +2% | +$12.7M | 2.62% | 17 |
|
2019
Q3 | $710M | Sell |
11,198,093
-327,940
| -3% | -$20.8M | 3.19% | 14 |
|
2019
Q2 | $779M | Buy |
11,526,033
+234,100
| +2% | +$15.8M | 3.58% | 11 |
|
2019
Q1 | $734M | Buy |
11,291,933
+539,793
| +5% | +$35.1M | 3.52% | 10 |
|
2018
Q4 | $673M | Buy |
10,752,140
+236,540
| +2% | +$14.8M | 3.74% | 11 |
|
2018
Q3 | $812M | Sell |
10,515,600
-63,975
| -0.6% | -$4.94M | 4.09% | 7 |
|
2018
Q2 | $749M | Buy |
10,579,575
+696,200
| +7% | +$49.3M | 4.02% | 7 |
|
2018
Q1 | $745M | Sell |
9,883,375
-27,118
| -0.3% | -$2.04M | 4.13% | 7 |
|
2017
Q4 | $710M | Buy |
9,910,493
+5,026,015
| +103% | +$360M | 3.86% | 11 |
|
2017
Q3 | $396M | Buy |
+4,884,478
| New | +$396M | 2.39% | 18 |
|